Please assess the completion status of the following clinical trial:

Trial Title: Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patients on Basal Insulin Initiating Treatment With IDegLira in Routine Clinical Practice in Colombia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~1. Male or female, age above or equal to 18 years at the time of data collection.~2. Patient diagnosed with T2D greater than or equal to 12 months prior to data collection.~3. The decision to initiate treatment with commercially available IDegLira has been made by the patient and the treating physician before, which is independent from the decision to participate in this study.~4. Treated with basal insulin plus/minus OADs prior to initiating IDegLira.~5. Available and documented HbA1c measurement below or equal to 12 weeks prior to IDegLira initiation.~Exclusion criteria:~1. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.~2. Diagnosed with type 1 diabetes mellitus, maturity-onset diabetes of the young, latent autoimmune diabetes in adults, gestational diabetes or any hyperglycaemic state other than T2D.~3. Women known to be pregnant or breastfeeding during the conduct of the study.~4. Patients with basal-bolus insulin prior to IDegLira initiation.~5. Participation in another T2D clinical study that involves any clinical intervention or administration of an investigational drug within 3 months prior to initiating IDegLira.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IDegLira (Type: None): Adult patients with T2D who have initiated treatment with IDegLira a minimum of 26 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).